ANNE MARIE DEJOYA REEVE: Open Payments
NPI 1659887024 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,875 in 63 payments from 19 companies in 2025. Trend: 2023 $1,983 · 2024 $2,718 · 2025 $2,875
Food & beverage: $2,471Education: $404
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $521 |
| Novartis Pharmaceuticals Corporation | 6 | $444 |
| Daiichi Sankyo Inc. | 10 | $389 |
| Lilly USA, LLC | 4 | $236 |
| ABBVIE INC. | 5 | $212 |
| BeOne Medicines USA, Inc. | 10 | $211 |
| Kite Pharma, Inc. | 1 | $139 |
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| SOBI, INC | 1 | $119 |
| Astellas Pharma US Inc | 1 | $93 |
Products named: KYMRIAH, Niktimvo, BRUKINSA, Vanflyta, Venclexta, Enhertu, Yescarta, Monjuvi.
Industry payments across CA — which companies pay providers there.
